VANCOUVER, May 30 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) today
reported interim financial results (unaudited) for the three months ended
March 31, 2008. Amounts, unless specified otherwise, are expressed in Canadian
dollars and in accordance with Canadian Generally Accepted Accounting
Principles (Canadian GAAP).
